Natus Medical Inc (NASDAQ:NTUS)
| 17.98 BATS BZX Real-Time Price As of 3:05pm ET |  -0.17 / -0.94%Today’s Change | 17.37 Today|||52-Week Range 34.89 | -45.50% Year-to-Date |
Latest NTUS News | Press Releases
| Natus Medical Incorporated (NTUS) Q2 2020 Earnings Call Transcript Jul 31 / MotleyFool.com - Paid Partner Content | Notable earnings after Thursday's close Jul 29 / Seeking Alpha - Paid Partner Content |
| Natus Medical EPS beats by $0.08, misses on revenue Jul 30 / Seeking Alpha - Paid Partner Content | White Brook Capital LLC Q2 2020 Commentary Jul 24 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 18.15 |
| Today’s open | 18.24 |
| Day’s range | 17.93 - 18.30 |
| Volume | 11,212 |
| Average volume (3 months) | 312,387 |
| Market cap | $628.0M |
Data as of 3:05pm ET, 08/07/2020
Growth & Valuation
| Earnings growth (last year) | +32.86% |
| Earnings growth (this year) | -91.13% |
| Earnings growth (next 5 years) | +22.00% |
| Revenue growth (last year) | -6.73% |
| P/E ratio | NM |
| Price/Sales | 2.24 |
| Price/Book | 1.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZYXIZynex Inc | +0.30 | +1.79% |
| VRAYViewRay Inc | +0.05 | +1.57% |
| AXGNAxoGen Inc | +0.18 | +1.49% |
| VAPOVapotherm Inc | -2.60 | -7.99% |
Data as of 3:05pm ET, 08/07/2020
Financials
| Next reporting date | October 21, 2020 |
| EPS forecast (this quarter) | $0.01 |
| Annual revenue (last year) | $495.2M |
| Annual profit (last year) | -$15.7M |
| Net profit margin | -3.16% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Pleasanton, California |
Forecasts
